Active substance
Nadolol
- US FDA 15
- Health Canada 5
- US price lines 3
- NHS prices 1
- Safety 2
US FDA United States — FDA approvals (Drugs@FDA)
| Product | Strength | Form · route | Applicant | Status | First approved |
|---|---|---|---|---|---|
| NADOLOL | 20MG; 40MG; 80MG | tablet · oral | RISING | Prescription | 31 Oct 1993 |
| NADOLOL | 20MG; 40MG; 80MG | tablet · oral | SANDOZ | Prescription | 9 Nov 1995 |
| NADOLOL | 40MG; 80MG; 20MG | tablet · oral | AUROBINDO PHARMA | Prescription | 16 Sep 2015 |
| NADOLOL | 20MG; 40MG; 80MG | tablet · oral | INVAGEN PHARMS | Prescription | 18 Dec 2015 |
| NADOLOL | 20MG; 40MG; 80MG | tablet · oral | AMNEAL PHARMS CO | Prescription | 2 Jun 2017 |
| NADOLOL | 20MG; 40MG; 80MG | tablet · oral | ZYDUS PHARMS | Prescription | 28 Jul 2017 |
| NADOLOL | 20MG; 40MG; 80MG | tablet · oral | CHARTWELL RX | Prescription | 5 Oct 2017 |
| NADOLOL | 20MG; 40MG; 80MG | tablet · oral | REGCON HOLDINGS | Prescription | 23 Jul 2018 |
| NADOLOL | 20MG; 40MG; 80MG | tablet · oral | SOMERSET THERAPS LLC | Prescription | 13 Sep 2019 |
| NADOLOL | 20MG; 40MG; 80MG | tablet · oral | ALEMBIC | Prescription | 2 Jun 2023 |
| CORGARD | 40MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 80MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**; 120MG; 160MG; 20MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** | tablet · oral | USWM | Discontinued | 10 Dec 1979 |
| NADOLOL | 80MG; 120MG; 160MG | tablet · oral | TEVA PHARMS | Discontinued | 31 Aug 1994 |
| NADOLOL | 80MG; 120MG; 160MG | tablet · oral | HERITAGE PHARMA | Discontinued | 24 Jan 1996 |
| NADOLOL | 20MG; 40MG | tablet · oral | HERITAGE PHARMA | Discontinued | 30 Aug 1996 |
| NADOLOL | 20MG; 40MG; 80MG | tablet · oral | INGENUS PHARMS LLC | Discontinued | 1 Jun 2018 |
Canada Canada — marketed products (Health Canada)
| Brand | DIN | Strength | Form · route | Company |
|---|---|---|---|---|
| APO-NADOLOL | 00782467 | 80 MG | TABLET · ORAL | APOTEX INC |
| APO-NADOLOL | 00782475 | 160 MG | TABLET · ORAL | APOTEX INC |
| APO-NADOLOL | 00782505 | 40 MG | TABLET · ORAL | APOTEX INC |
| MINT-NADOLOL | 02496380 | 40 MG | TABLET · ORAL | MINT PHARMACEUTICALS INC |
| MINT-NADOLOL | 02496399 | 80 MG | TABLET · ORAL | MINT PHARMACEUTICALS INC |
Prices — United States and England
| Source | Product as listed | Price | Unit / pack | Date |
|---|---|---|---|---|
| US NADAC | NADOLOL 20 MG TABLET | $0.14654 | per EA | 23 Sep 2026 |
| US NADAC | NADOLOL 40 MG TABLET | $0.26544 | per EA | 23 Sep 2026 |
| US NADAC | NADOLOL 80 MG TABLET | $0.27372 | per EA | 23 Sep 2026 |
| NHS Drug Tariff | Nadolol 80mg tablets | £19.45 | 28 tablet | 1 Oct 2026 |
NADAC: average price US retail pharmacies pay to buy the medicine. NHS Drug Tariff Part VIIIA: basic price reimbursed to pharmacies in England and Wales.
Safety signals and safety-related labeling changes
- US FDA 22 Dec 2023 CORGARD — safety-related labeling change
Labeling sections changed: Warnings and Precautions; Adverse Reactions - US FDA 26 May 2021 CORZIDE — safety-related labeling change
Labeling sections changed: Warnings and Precautions
Values as published by each source: SFDA human drug list (4-2026, as published by the Council of Health Insurance; indications from the CHI Daman Drug Formulary), Drugs@FDA, EMA medicines data, Health Canada Drug Product Database (Open Government Licence – Canada), CMS NADAC, NHS Drug Tariff Part VIIIA (NHSBSA Copyright, Open Government Licence v3.0), WHO Model List of Essential Medicines (CC BY 3.0 IGO; regrouped by active substance, not created by WHO), EMA PRAC, US FDA safety-related labeling changes and MHRA Drug Safety Update (Open Government Licence v3.0). Sources and reuse. Not a substitute for the official registers or the product information.